Cargando…

EEG complexity as a biomarker for autism spectrum disorder risk

BACKGROUND: Complex neurodevelopmental disorders may be characterized by subtle brain function signatures early in life before behavioral symptoms are apparent. Such endophenotypes may be measurable biomarkers for later cognitive impairments. The nonlinear complexity of electroencephalography (EEG)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosl, William, Tierney, Adrienne, Tager-Flusberg, Helen, Nelson, Charles
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050760/
https://www.ncbi.nlm.nih.gov/pubmed/21342500
http://dx.doi.org/10.1186/1741-7015-9-18
_version_ 1782199385080201216
author Bosl, William
Tierney, Adrienne
Tager-Flusberg, Helen
Nelson, Charles
author_facet Bosl, William
Tierney, Adrienne
Tager-Flusberg, Helen
Nelson, Charles
author_sort Bosl, William
collection PubMed
description BACKGROUND: Complex neurodevelopmental disorders may be characterized by subtle brain function signatures early in life before behavioral symptoms are apparent. Such endophenotypes may be measurable biomarkers for later cognitive impairments. The nonlinear complexity of electroencephalography (EEG) signals is believed to contain information about the architecture of the neural networks in the brain on many scales. Early detection of abnormalities in EEG signals may be an early biomarker for developmental cognitive disorders. The goal of this paper is to demonstrate that the modified multiscale entropy (mMSE) computed on the basis of resting state EEG data can be used as a biomarker of normal brain development and distinguish typically developing children from a group of infants at high risk for autism spectrum disorder (ASD), defined on the basis of an older sibling with ASD. METHODS: Using mMSE as a feature vector, a multiclass support vector machine algorithm was used to classify typically developing and high-risk groups. Classification was computed separately within each age group from 6 to 24 months. RESULTS: Multiscale entropy appears to go through a different developmental trajectory in infants at high risk for autism (HRA) than it does in typically developing controls. Differences appear to be greatest at ages 9 to 12 months. Using several machine learning algorithms with mMSE as a feature vector, infants were classified with over 80% accuracy into control and HRA groups at age 9 months. Classification accuracy for boys was close to 100% at age 9 months and remains high (70% to 90%) at ages 12 and 18 months. For girls, classification accuracy was highest at age 6 months, but declines thereafter. CONCLUSIONS: This proof-of-principle study suggests that mMSE computed from resting state EEG signals may be a useful biomarker for early detection of risk for ASD and abnormalities in cognitive development in infants. To our knowledge, this is the first demonstration of an information theoretic analysis of EEG data for biomarkers in infants at risk for a complex neurodevelopmental disorder.
format Text
id pubmed-3050760
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30507602011-04-06 EEG complexity as a biomarker for autism spectrum disorder risk Bosl, William Tierney, Adrienne Tager-Flusberg, Helen Nelson, Charles BMC Med Research Article BACKGROUND: Complex neurodevelopmental disorders may be characterized by subtle brain function signatures early in life before behavioral symptoms are apparent. Such endophenotypes may be measurable biomarkers for later cognitive impairments. The nonlinear complexity of electroencephalography (EEG) signals is believed to contain information about the architecture of the neural networks in the brain on many scales. Early detection of abnormalities in EEG signals may be an early biomarker for developmental cognitive disorders. The goal of this paper is to demonstrate that the modified multiscale entropy (mMSE) computed on the basis of resting state EEG data can be used as a biomarker of normal brain development and distinguish typically developing children from a group of infants at high risk for autism spectrum disorder (ASD), defined on the basis of an older sibling with ASD. METHODS: Using mMSE as a feature vector, a multiclass support vector machine algorithm was used to classify typically developing and high-risk groups. Classification was computed separately within each age group from 6 to 24 months. RESULTS: Multiscale entropy appears to go through a different developmental trajectory in infants at high risk for autism (HRA) than it does in typically developing controls. Differences appear to be greatest at ages 9 to 12 months. Using several machine learning algorithms with mMSE as a feature vector, infants were classified with over 80% accuracy into control and HRA groups at age 9 months. Classification accuracy for boys was close to 100% at age 9 months and remains high (70% to 90%) at ages 12 and 18 months. For girls, classification accuracy was highest at age 6 months, but declines thereafter. CONCLUSIONS: This proof-of-principle study suggests that mMSE computed from resting state EEG signals may be a useful biomarker for early detection of risk for ASD and abnormalities in cognitive development in infants. To our knowledge, this is the first demonstration of an information theoretic analysis of EEG data for biomarkers in infants at risk for a complex neurodevelopmental disorder. BioMed Central 2011-02-22 /pmc/articles/PMC3050760/ /pubmed/21342500 http://dx.doi.org/10.1186/1741-7015-9-18 Text en Copyright ©2011 Bosl et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bosl, William
Tierney, Adrienne
Tager-Flusberg, Helen
Nelson, Charles
EEG complexity as a biomarker for autism spectrum disorder risk
title EEG complexity as a biomarker for autism spectrum disorder risk
title_full EEG complexity as a biomarker for autism spectrum disorder risk
title_fullStr EEG complexity as a biomarker for autism spectrum disorder risk
title_full_unstemmed EEG complexity as a biomarker for autism spectrum disorder risk
title_short EEG complexity as a biomarker for autism spectrum disorder risk
title_sort eeg complexity as a biomarker for autism spectrum disorder risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050760/
https://www.ncbi.nlm.nih.gov/pubmed/21342500
http://dx.doi.org/10.1186/1741-7015-9-18
work_keys_str_mv AT boslwilliam eegcomplexityasabiomarkerforautismspectrumdisorderrisk
AT tierneyadrienne eegcomplexityasabiomarkerforautismspectrumdisorderrisk
AT tagerflusberghelen eegcomplexityasabiomarkerforautismspectrumdisorderrisk
AT nelsoncharles eegcomplexityasabiomarkerforautismspectrumdisorderrisk